Project Details
Project Description
| Status | Finished |
|---|---|
| Effective start/end date | 8/05/24 → 7/05/26 |
Keywords
- Clinical Trials
- ACTM-838-01
Clinical Trial Phase
- Phase I
A Phase 1a/1b Open-label, Dose-Escalation and Expansion Study of ACTM-838 as a Single Agent in Patients with Advanced Solid Tumors
- Haydon, Andrew (Primary Chief Investigator (PCI))
- Brooks, Christine (Project Manager)
Project: Research